Find clinical, allied health, care team, and healthcare operations openings using one smart search field across cities, regions, and employers.
Alnylam Pharmaceuticals
Overview
The Scientist will identify and validate novel siRNA drug targets for neurodegenerative diseases and lead early-stage programs through lead selection. They will design proof-of-concept experiments in vitro and in vivo while managing collaborations with CROs and academic partners.
Quick view →
Compensation
$110,400 - $165,600 / YEAR
Posted
25 days ago
The role involves identifying novel drug targets across various indications and tissues using human genetics and multi-omics. The scientist will lead preclinical proof-of-concept studies and oversee lead discovery activities to validate target feasibility.
1 month ago
